BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26521102)

  • 1. Comorbidity in chronic obstructive pulmonary disease.
    Negewo NA; McDonald VM; Gibson PG
    Respir Investig; 2015 Nov; 53(6):249-58. PubMed ID: 26521102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
    Corlateanu A; Covantev S; Mathioudakis AG; Botnaru V; Siafakas N
    Respir Investig; 2016 Nov; 54(6):387-396. PubMed ID: 27886849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comorbidities in COPD: a new challenge in clinical practice].
    Couillard A; Veale D; Muir JF
    Rev Pneumol Clin; 2011 Jun; 67(3):143-53. PubMed ID: 21665077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comorbidities in COPD].
    de Miguel Díez J; García TG; Maestu LP
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease.
    Van Remoortel H; Hornikx M; Langer D; Burtin C; Everaerts S; Verhamme P; Boonen S; Gosselink R; Decramer M; Troosters T; Janssens W
    Am J Respir Crit Care Med; 2014 Jan; 189(1):30-8. PubMed ID: 24219412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
    Bernardo I; Bozinovski S; Vlahos R
    Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease and its comorbidities.
    Panetta NL; Krachman S; Chatila WM
    Panminerva Med; 2009 Jun; 51(2):115-23. PubMed ID: 19776712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.
    López Varela MV; Montes de Oca M; Halbert R; Muiño A; Tálamo C; Pérez-Padilla R; Jardim JR; Valdivia G; Pertuzé J; Menezes AM;
    Arch Bronconeumol; 2013 Nov; 49(11):468-74. PubMed ID: 23856439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease as comorbidity in patients admitted to a university hospital: a cross-sectional study.
    Nielsen HM; Rødsgaard PA; Weinreich UM
    Clin Respir J; 2014 Jul; 8(3):274-80. PubMed ID: 23911061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common geriatric conditions and disabilities in older persons with chronic obstructive pulmonary disease.
    Landi F; Pistelli R; Abbatecola AM; Barillaro C; Brandi V; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S29-34. PubMed ID: 22209927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.
    Patel AR; Hurst JR
    Expert Rev Respir Med; 2011 Oct; 5(5):647-62. PubMed ID: 21955235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD and its comorbidities: Impact, measurement and mechanisms.
    Negewo NA; Gibson PG; McDonald VM
    Respirology; 2015 Nov; 20(8):1160-71. PubMed ID: 26374280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comorbidities with COPD].
    Hashimoto S; Gon Y; Mizumura K
    Nihon Rinsho; 2016 May; 74(5):850-7. PubMed ID: 27254958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.